Responses
Oral Presentations
Novel insights into B and T cell immunity in rheumatic disease
OP0205 Clinical and Preclinical Assessment of The Anti-MCAM Monoclonal Antibody PRX003, A Potential Novel Treatment for Th17-Mediated Inflammatory Diseases
Compose a Response to This Article
Other responses
No responses have been published for this article.